Advertisement

Metabolismus und enterale Resorption herzwirksamer Glykoside / Intestinal Absorption and Metabolism of Cardiac Glycosides

  • F. Lauterbach
Chapter

Zusammenfassung

Bei prinzipiell gleichartiger positiv-inotroper Grundwirkung der Herz-glykoside erstrecken sich nach klinischer und pharmakologischer Erfahrung ihre Sekundärqualitäten wie Resorptions- und Abklingquote über einen weiten Bereich.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Abel, R.M., R.J. Luchi, G.W. Peskin, H.L. Conn, Jr., and L.D. Miller: J. Pharmacol, exp. Ther. 150, 463 (1965).Google Scholar
  2. 2.
    Ashley, J.J., B.T. Brown, G.T. Okita, and S.E. Wright: J. biol. Chem. 232, 315 (1958).PubMedGoogle Scholar
  3. 3.
    Benthe, H.F., u. K. Chenpanich: Arzneimittel-Forsch. 15, 486 (1965).Google Scholar
  4. 4.
    Brodie, B.B.: In: T.B. Binns: Absorption and distribution of drugs, p. 16. Edinburgh-London: E.& S. Livingstone LTD. 1964.Google Scholar
  5. 5.
    Brown, B.T., S.E. Wright, and G.T. Okita: Nature (Lond.) 180, 607 (1957).CrossRefGoogle Scholar
  6. 6.
    Buchtela, K., K. Drexler, H. Hackl, M. Königstein u. J. Schläger: Arzneimittel-Forsch. 18, 295 (1968).Google Scholar
  7. 7.
    Cox, E., G. ROxburgh, and S.E. Wright: J. Pharm. Pharmacol. 11, 535 (1959).PubMedCrossRefGoogle Scholar
  8. 8.
    —, and S.E. Wright: J. Pharmacol, exp. Ther. 126, 117 (1959).Google Scholar
  9. 9.
    Doherty, J.E., W.J. Flanigan, W.H. Perkins, and G.L. Ackerman: Circulation 35, 298 (1967).PubMedCrossRefGoogle Scholar
  10. 10.
    —: W.H. Perkins, and W.J. Flanigan: Ann. intern. Med. 66, 116 (1967).PubMedCrossRefGoogle Scholar
  11. 11.
    — and G.K. Mitchell: Arch, intern. Med. 108, 531 (1961).CrossRefGoogle Scholar
  12. 12.
    Dutta, S., and B.H. Marks: Biochem. Pharmacol. 12, 32 (1963).Google Scholar
  13. 13.
    —: and C.K. Smith: J. Pharmacol, exp. Ther. 142, 223 (1963).Google Scholar
  14. 14.
    Engler, R., P. Holtz u. H.W. Raudonat: Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 233, 393 (1958).CrossRefGoogle Scholar
  15. 15.
    Förster, W., and S. Schulzeck: Biochem. Pharmacol. 17, 489 (1968).PubMedCrossRefGoogle Scholar
  16. 16.
    Forth, W., E. Furukawa u. W. Kümmel: Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 262, 53 (1969).CrossRefGoogle Scholar
  17. 17.
    —, u. W. Rummel: Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 260, 112 (1968).CrossRefGoogle Scholar
  18. 18.
    Gillissen, J., R. Hotovy u. K. Lingner: Arzneimittel-Forsch. 14, 335 (1964).Google Scholar
  19. 19.
    Greeff, K., D. Schwarzmann u. G. Waschulzik: Arzneimittel-Forsch. 15, 483 (1965).Google Scholar
  20. 20.
    Griffin, C.L., and S.H. Burstein: Biochem. Pharmacol. 16, 447 (1967).PubMedCrossRefGoogle Scholar
  21. 21.
    Haberland, G.: Arzneimittel-Forsch. 15, 481 (1965).Google Scholar
  22. 22.
    Hackenberg, U.: Arzneimittel-Forsch. 3, 549 (1953).Google Scholar
  23. 23.
    Harrison, C.E., Jr., R.O. Brandenburg, P.A. Ongley, A.L. Orvis, and C.A. Owen, Jr.: J. Lab. clin. Med. 67, 764 (1966).PubMedGoogle Scholar
  24. 24.
    Herrmann, R.G., R.J. Parker, F.G. Henderson, and K.K. Chen: Proc. Soc. exp. Biol. (N.Y.) 109, 646 (1962).CrossRefGoogle Scholar
  25. 25.
    Herrmann, L, u. K. Repke: Mber. dtsch. Akad. Wiss. 5, 140 (1963).Google Scholar
  26. 26.
    —: Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 247, 19 (1964).CrossRefGoogle Scholar
  27. 27.
    —: Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 247, 35 (1964).CrossRefGoogle Scholar
  28. 28.
    —: Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 248, 351 (1964).Google Scholar
  29. 29.
    —: Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 248, 370 (1964).Google Scholar
  30. 30.
    Hunger, A., u. T. Reichstein: Chem. Ber. 85, 635 (1952).CrossRefGoogle Scholar
  31. 31.
    Kohli, J.D., and M.M. Vohra: Arch. int. Pharmacodyn. 126, 412 (1960).PubMedGoogle Scholar
  32. 32.
    Kraupp, O., G. Raberger u. W. Grossmann: Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 260, 330 (1968).CrossRefGoogle Scholar
  33. 33.
    Kroneberg, G., W. Schaumann u. K. Stoepel: Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 243, 91 (1962).Google Scholar
  34. 34.
    Kupferberg, H.J., and L.S. Schanker: Amer. J. Physiol. 214, 1048 (1968).PubMedGoogle Scholar
  35. 35.
    Kurbjuweit, H.-G.: Arzneimittel-Forsch. 14, 716 (1964).Google Scholar
  36. 36.
    Lahrtz, H., u. P.A. van Zwieten: Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 260, 165 (1968).CrossRefGoogle Scholar
  37. 37.
    Lauterbach, F.: Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 246, 36 (1963).CrossRefGoogle Scholar
  38. 38.
    —: Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 247, 71 (1964).CrossRefGoogle Scholar
  39. 39.
    — Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 247, 391 (1964).CrossRefGoogle Scholar
  40. 40.
    — Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 257, 432 (1967).CrossRefGoogle Scholar
  41. 41.
    —: Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 260, 167 (1968).CrossRefGoogle Scholar
  42. 42.
    —: Biochim. biophys. Acta (Amst.) 150, 146 (1968).Google Scholar
  43. 43.
    —, u. K. Repke: Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 239, 196 (1960).CrossRefGoogle Scholar
  44. 44.
    —: Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 240, 45 (1960).CrossRefGoogle Scholar
  45. 45.
    —, u. G. Vogel: Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 259, 248 (1968).CrossRefGoogle Scholar
  46. 46.
    Lendle, L.: Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 109, 35 (1925).CrossRefGoogle Scholar
  47. 47.
    —:, u. W. Busse: Klin. Wschr. 30, 264 (1952).PubMedCrossRefGoogle Scholar
  48. 48.
    Lingner, K., R. Hotovy, J. Gillissen u. W. Küssner: Arzneimittel-Forsch. 13, 764 (1963).Google Scholar
  49. 49.
    — K. Irmscher, W. Küssner, R. Hotovy u. J. Gillissen: Arzneimittel-Forsch. 13, 142 (1963).Google Scholar
  50. 50.
    Marcus, F.I., G.J. Kapadia, and G.G. Kapadia: J. Pharmacol, exp. Ther. 145, 203 (1964).Google Scholar
  51. 51.
    Marcus, F.I., A. Peterson, A. Salel, J. Scully, and G.G. Kapadia: J. Pharmacol, exp. Ther. 152, 372 (1966).Google Scholar
  52. 52.
    Marks, B.H., S. Dutta, J. Gauthier, and D. Elliott: J. Pharmacol, exp. Ther. 145, 351 (1964).Google Scholar
  53. 53.
    Martin, J.F., and S.E. Wright: J. Pharmacol, exp. Ther. 128, 329 (1960).Google Scholar
  54. 54.
    Megges, K., u. K. Repke: Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 241, 534 (1961).CrossRefGoogle Scholar
  55. 55.
    — Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 243, 330 (1962).CrossRefGoogle Scholar
  56. 56.
    In: E. Wilbrandt and P. Lindgren (Ed.), New aspects of cardiac glycosides. Proceedings of the First International Pharmacological Meeting, 1961, Vol.3, p. 271. Oxford-London-New York-Paris: Pergamon Press 1963.Google Scholar
  57. 57.
    Moerman, E.: Arch. int. Pharmacodyn. 156, 489 (1965).PubMedGoogle Scholar
  58. 58.
    Neumann, W.: Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 208, 87 (1949).CrossRefGoogle Scholar
  59. 59.
    Nyary, A. v.: Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 165, 432 (1932).CrossRefGoogle Scholar
  60. 60.
    Okita, G.T., F.E. Kelsey, P.J. Talso, L.B. Smith, and E.M.K. Geiling: Circulation 7, 161 (1953).PubMedCrossRefGoogle Scholar
  61. 61.
    Reinert, H.: Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 215, 1 (1952).Google Scholar
  62. 62.
    Repke, K.: Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 237, 34 (1959).Google Scholar
  63. 63.
    —: Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 237, 155 (1959).Google Scholar
  64. 64.
    —: Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 240, 2 (1960/61).CrossRefGoogle Scholar
  65. 65.
    —: In: W. Wilbrandt and P. Lindgren (Ed.): New aspects of cardiac glycosides. Proceeding of the First International Pharmacological Meeting, 1961, Vol. 3, p. 47. Oxford-London-New York-Paris: Pergamon Press 1963.Google Scholar
  66. 66.
    —, and L.T. Samuels: Biochemistry 3, 685 (1964).PubMedCrossRefGoogle Scholar
  67. 67.
    —: Biochemistry 3, 689 (1964).PubMedCrossRefGoogle Scholar
  68. 68.
    Rothlin, E., u. R. Bircher: Ergebn. inn. Med. Kinderheilk. 5, 457 (1954).PubMedCrossRefGoogle Scholar
  69. 69.
    Schanker, L.S.: In N.J. Harper and A.B. Simmonds: Advances in drug research, Vol. 1, p. 71. London-New York: Academic Press 1964.Google Scholar
  70. 70.
    Scholtan, W.: Arzneimittel-Forsch. 18, 505 (1968).Google Scholar
  71. 71.
    —: K. Schlossmann u. H. Rosenkranz: Arzneimittel-Forsch. 16, 109 (1966).Google Scholar
  72. 72.
    Simon, M., and S.E. Wright: J. Pharm. Pharmacol. 12, 767 (1960).CrossRefGoogle Scholar
  73. 73.
    Stahl, E., u. U. Kaltenbach: J. Chromatogr. 5, 458 (1961).CrossRefGoogle Scholar
  74. 74.
    Švec, F.: Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 192, 18 (1939).CrossRefGoogle Scholar
  75. 75.
    —, u. A. Hasik: Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 199, 387 (1942).CrossRefGoogle Scholar
  76. 76.
    Thomas, R.E., and S.E. Wright: J. Pharm. Pharmacol. 17, 459 (1965).PubMedCrossRefGoogle Scholar
  77. 77.
    Vogel, G., u. F. Lauterbach: Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 244, 334 (1963).CrossRefGoogle Scholar
  78. 78.
    Wagener, H.-H.: Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 255, 365 (1966).CrossRefGoogle Scholar
  79. 79.
    Weiss, D., E. Meyer-Elmen u. A. Ruiz-Torres: Klin. Wschr. 46, 835 (1968).Google Scholar
  80. 80.
    White, W.F., and O. Gisvold: J. Amer, pharm. Ass. 41, 42 (1952).CrossRefGoogle Scholar
  81. 81.
    Wright, S.E.: J. Pharm. Pharmacol. 14, 613 (1962).PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1969

Authors and Affiliations

  • F. Lauterbach
    • 1
  1. 1.Biologisches Institut MadausKöln-MerheimDeutschland

Personalised recommendations